Michael Naslund
Papers
1
Total Citations
46
H-Index
1
About
Dr. Michael Naslund is a leading urologic oncologist whose research has fundamentally shaped the clinical management of benign prostatic hyperplasia (BPH) and prostate cancer. His work bridges the critical gap between specialized urology and primary care, ensuring that frontline physicians are equipped to recognize and manage these common, morbid conditions in aging men. His most cited paper, "Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians" (2010, 46 citations), provides a focused, practical synthesis of evolving treatment paradigms, from watchful waiting to advanced surgical and medical interventions. This overview has become a cornerstone reference for clinicians navigating the complexities of BPH and prostate cancer diagnosis and therapy. Beyond this influential review, Dr. Naslund’s contributions extend to advancing minimally invasive treatments and improving patient outcomes through evidence-based protocols. His work is characterized by a commitment to translating complex urologic science into actionable guidance, directly impacting the quality of life for millions of men. For students and researchers, Dr. Naslund exemplifies how targeted, clinically relevant research can bridge specialties and elevate the standard of care.
Research Focus
Key Achievements
Top Papers
- 1